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Abstract
Background: Mouse virulence assessments of certain Mycobacterium tuberculosis mutants have revealed an
immunopathology defect in which high tissue CFU counts are observed but the tissue pathology and lethality are
reduced. M. tuberculosis mutants which grow and persist in the mouse lungs, but have attenuated disease
progression, have the immunopathology (imp) phenotype. The antigenic properties of these strains may alter the
progression of disease due to a reduction in host immune cell recruitment to the lungs resulting in disease
attenuation and prolonged host survival.
Results: In this study we focused on the mouse immune response to one such mutant; the M. tuberculosis ΔsigC
mutant. Aerosol infection of DBA/2 and SCID mice with the M. tuberculosis ΔsigC mutant, complemented mutant
and wild type strain showed proliferation of mutant bacilli in mouse lungs, but with decreased inflammation and
mortality in DBA/2 mice. SCID mice shared the same phenotype as the DBA/2 mice in response to the ΔsigC
mutant, however, they succumbed to the infection faster. Bronchoalveolar lavage (BAL) fluid analysis revealed
elevated numbers of infiltrating neutrophils in the lungs of mice infected with wild type and complemented ΔsigC
mutant strains but not in mice infected with the ΔsigC mutant. In addition, DBA/2 mice infected with the ΔsigC
mutant had reduced levels of TNF-α, IL-1β, IL-6 and IFN-γ in the lungs. Similarly, there was a reduction in
proinflammatory cytokines in the lungs of SCID mice. In contrast to the mouse model, the ΔsigC mutant had
reduced initial growth in guinea pig lungs. A possible mechanism of attenuation in the ΔsigC mutant may be a
reduction in neutrophilic-influx in the alveolar spaces of the lungs, and decreased proinflammatory cytokine
secretion. In contrast to mouse data, the M. tuberculosis ΔsigC mutant proliferates slowly in guinea pig lungs, a
setting characterized by caseating necrosis.
Conclusion: Our observations suggest that the immunopathology phenotype is associated with the inability to
trigger a strong early immune response, resulting in disease attenuation. While macrophages and T cells have been
shown to be important in containing M. tuberculosis disease our study has shown that neutrophils may also play
an important role in the containment of this organism.
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According to the latest WHO fact sheet, tuberculosis (TB)
causes about 2 million deaths every year and 2 billion of
the world's population is infected with Mycobacterium
tuberculosis [1,2]. TB co-infection is also the number one
killer of HIV patients which implicates the importance of
a healthy immune system in controlling TB. M. tuberculosis
is transmitted mainly by the respiratory route, and the pri-
mary site of infection is the lung. Following inhalation,
these bacilli are phagocytosed by resident alveolar macro-
phages which recruit neutrophils, T cells and monocytes,
and promote the local production of cytokines [3-5]. In
vitro, M. tuberculosis triggers a Th1 type immune response
which results in the release of TNF-α, IL-12 and IFN-γ
[6,7]. These observations have been further substantiated
in vivo using the mouse model [8-12]. While macrophages
and T cells play key roles in the immune containment of
M. tuberculosis, the role of other immune cells has received
less attention. A recent study found that enhanced recruit-
ment of neutrophils in lungs of some mouse strains is
associated with increased susceptibility to M. tuberculosis
infection [13], indicating that neutrophils may play a
more important role during M. tuberculosis infection than
previously thought.
Characterizing the exact roles for each of these compo-
nents has been challenging and cytokine studies have pro-
duced conflicting results. IL-12 may be crucial in clearing
M. tuberculosis infection in BALB/c mice but in a more
resistant mouse strain, like C57BL/6, its effects are mar-
ginal [10]. IFN-γ is an important cytokine in controlling
intracellular M. tuberculosis [8,11], but M. tuberculosis-
infected-macrophages can secrete IL-6 which in turn pre-
vents uninfected macrophages from responding to IFN-γ
[14,15]. This negative feedback loop may enable the bac-
teria to persist in the host. Despite the inconsistencies, the
host's immune system is a factor in determining the pro-
gression of the infection.
Antigenic properties of the different M. tuberculosis
mutants also alter disease progression. Strains which can
grow and persist in mouse lungs without eliciting severe
damage have the immunopathology (imp) phenotype
[16,17]. This phenotype results in reduced host immune
cell recruitment to the lungs and prolonged host survival.
Several imp mutants have been generated and tested in
mice in order to characterize changes in the host tissues as
well as in their immune responses. Some of these imp
mutants include sigH, sigE, sigF, sigD, whiB3 and dnaE2
[16,18-23]. In the case of the sigH mutant, four weeks after
the mice were infected, there were fewer CD4 and CD8 T
cells recruited to lung tissues in comparison to mice
infected with the wild type strain [16]. The number of
IFN-γ and TNF-α expressing CD4 T cells in these mice was
also reduced. In order to determine if the imp phenotype
can only be expressed in immunocompetent mice, SCID
mice were infected with sigH, sigE, and sigD separately
[16,20,21,23]. Results from these studies indicate that the
imp phenotype appears to be dependent on functional
cell-mediated immunity which the SCID mice lack.
To determine when these mutants begin expressing their
phenotype in the host tissue, gene expression studies as
well as RT-PCR were carried out. whiB3 [19,24] and sigH
[16] for example were found to be maximally induced
during the early phase of mouse lung infection while sigF
[22] was highly expressed in stationary growth phase and
was associated with late-stage disease in mice. Most of
these studies focused on bacterial survival in the host
rather than the host's immune response. However, these
mutants could reveal how the host immune system con-
tains M. tuberculosis infection.
The RNA polymerase sigma factors of M. tuberculosis, such
as SigC, confer DNA binding at specific promoter sites and
play a role in transcription initiation. In a previous study
we found that the ΔsigC mutant had an imp phenotype
where the mutant persists in mouse lungs but fails to
cause mortality as rapidly as the wild-type. SigC was
found to be essential for lethality of M. tuberculosis in mice
[20]. To address the question of host factors, we infected
mice with the ΔsigC mutant and assessed cell infiltration
patterns and cytokine levels during different time points
after aerosol infection. We found that mice infected with
the wild type M. tuberculosis strain had higher levels of
inflammatory cytokines and infiltrating neutrophils when
compared to the ΔsigC mutant infected mice. The same
observation was also noted when SCID mice were
exposed to the ΔsigC mutant strain. We also characterized
the pattern of M. tuberculosis ΔsigC mutant infection in
guinea pigs and found dramatically reduced bacterial pro-
liferation in contrast to the mouse pattern. Our observa-
tions suggest that the imp phenotype is associated with the
inability to trigger a strong early immune response, which
may result in disease attenuation.
Results
M. tuberculosis ΔsigC mutant infection in 
immunocompetent mice
We infected three groups of mice separately with the ΔsigC
mutant, the ΔsigC complemented mutant, and the wild
type parental strain, CDC1551. Bacterial growth in the
lungs of DBA/2 mice was observed to increase one week
post infection and to plateau at week 4 for both the
CDC1551 and ΔsigC complemented mutant groups (fig-
ure 1A). While growth of the ΔsigC mutant paralleled
those of the wild type and complemented strains for the
first week, its rate of proliferation slowed from week 2 to
week 4 (figure 1A). A similar outcome was detected in an
earlier study with DBA/2 mice [20]. At 28 days the ΔsigCPage 2 of 14
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BMC Microbiology 2008, 8:151 http://www.biomedcentral.com/1471-2180/8/151mutant attained CFU counts which were 1 log unit lower
than the CDC1551 and ΔsigC complemented mutant
groups. This observation persisted up to day 120. At the
same time mice exposed to the ΔsigC mutant remained
healthy and alive for an extended time in comparison to
the CDC1551 and ΔsigC complemented mutant groups
all of which died by 200 days (figure 1B). Haematoxylin-
eosin staining of lungs at day 120 from the complemented
ΔsigC mutant and CDC1551 infected groups confirmed
that these lungs had extensive internal damage in contrast
to the ΔsigC mutant group (figure 1C; a, b and 1C). Ziehl-
Neelsen staining confirmed the presence of fewer bacilli
in the ΔsigC mutant group (figure 1C; d, e and 1f). These
observations indicated that milder lung pathology, sec-
ondary to reduced bacterial growth, can contribute to host
survival.
Differential cellular infiltration in alveolar spaces seen 
with the ΔsigC mutant
The role of resident alveolar macrophages in eliminating
invading bacteria in the lung has been widely accepted
[25,26]. However, less is known regarding the role of pol-
ymorphonuclear cells in pulmonary tuberculosis. Thus,
we collected BAL fluid and employed cytology to classify
which cell types were recruited into the alveolar spaces
during disease progression in wild type versus ΔsigC
mutant infection. The total number of recovered cells
from BAL varied between less than 105 cells in non-
infected mice to 1 million cells at days 14 and 70 (figure
2). Throughout this study, the number of BAL cells from
mice infected with the ΔsigC mutant remained on average
less than 5 × 105 cells per mouse in contrast to mice
infected with the CDC1551 and the complemented ΔsigC
mutant (figure 2) whose counts were ~1 × 106. The lym-
phocyte population, which consisted of B, T and NK cells,
remained at a relatively constant level throughout the
study. Three cell types were detected via the cytospin
assay: lymphocytes, monocytes/macrophages and neu-
trophils. The majority of BAL cells were alveolar macro-
phages at about 90%, while lymphocytes and neutrophils
made up the remaining cell population. As time pro-
gressed, more neutrophils were found in the BAL fluid of
both the complemented ΔsigC mutant and CDC1551
infected groups (figure 2). At days 14 and 70, neutrophils
became the main cells in the lungs of these two groups,
but this was not observed in the lungs of ΔsigC infected
mice. Instead, decreased numbers of infiltrating neu-
trophils were observed at day 70 and day 120.
Proinflammatory cytokines were reduced in lung 
homogenates of ΔsigC infected DBA/2 mice
IL-1β acts on monocytes and macrophages to induce pro-
duction of TNF-α, IL-6 and IL-8 to enhance bactericidal
killing [27]. IL-1 β also acts on NK cells, in collaboration
with IL-2 and IFN-γ. IL-1β is required for T cell dependent
antibody production [28,29]. M. tuberculosis is a strong
inducer of chemokine expression. Chemokines are
involved in trafficking and recruiting cells in BAL as a
means to clear the infection [30]. In mice infected with the
ΔsigC mutant, the levels of TNF-α, IL-1β, IL-6 and IFN-γ
began to drop 14 days post infection and persisted
throughout the study while a significant reduction in
CCL-2 and CCL-5 levels was detected 70 days after infec-
tion (figure 3). In contrast the CDC1551 and ΔsigC com-
plemented mutant groups had elevated levels of TNF-α,
IL-1β, IL-6, IFN-γ, as well as chemokines (CCL-2 and CCL-
5) (figure 3). The IFN-γ level of the ΔsigC infected mice
remained low throughout the infection. A sharp drop of
the IFN-γ level was observed in the lung homogenates of
the CDC1551 infected group at day 120. However, this
difference was not statistically significant. IL-12 has been
reported to play an important role in disease progression
in M. tuberculosis infection [7,10,31], but no differences in
the level of this cytokine in all three groups were observed
(figure 3). TGF-1β, IL-4 and IL-10 (the latter two not
shown) also exhibited the same profile indicating that
these cytokines may be undetectable or inactive in the
lungs during this study period.
M. tuberculosis ΔsigC mutant infection in SCID mice
In DBA/2 mice infected with the ΔsigC mutant, lower
numbers of infiltrating neutrophils coincided with
DBA/2 mouse survival score and CFU countsFigure 1 (se  previous page)
DBA/2 mouse survival score and CFU counts. The mean CFU counts were obtained from the lung homogenates of 5 
mice per group and plated on 7H10 agar plates (A). ΔsigC mutant (), ΔsigC complemented mutant () and the wild type 
strain, CDC1551 (), CFU counts were obtained by homogenizing individual lungs from each group and plating on 7H10 agar 
plates. Day 1 CFU counts were performed to confirm the dose of bacilli in each group. Mice were sacrificed for CFU counts 
and immunological assays on days 7, 14, 28, 70 and 120 post infections. CFU counts from ΔsigC mutant infected mice were sig-
nificantly lower than in mice infected with either the CDC1551 or the complemented mutant strain (** = p < 0.01). (B) From 
the Kaplan-Meier survival curve, the median survival for the ΔsigC mutant infected group is more than 365 days post infection. 
This difference is significant with a log rank test p value of < 0.002. (C) Lungs of the three groups of DBA/2 mice infected with 
the ΔsigC mutant strain, the complemented ΔsigC mutant and the wild type strain, CDC1551, collected at day 120. Lung sec-
tions were stained with haematoxylin and eosin (H&E) (a-c) (Magnification ×20) and for acid fast bacilli (AFB) (d-f) (Magnifica-
tion ×1000).Page 4 of 14
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Cell types present in the bronchoalveolar lavage (BAL) fluid of DBA/2 mice following infection with the three different M. tb strainsFigure 2
Cell types present in the bronchoalveolar lavage (BAL) fluid of DBA/2 mice following infection with the three 
different M. tb strains. At the time points indicated BAL fluid of each mouse was collected, counted and a sample taken for 
cell type determination by cytospin analysis. 100 cells were counted and differential sorting of cell types was performed blindly 
in triplicate. Results are expressed as the mean number of total cells harvested per mouse ± standard deviation from 5 mice 
per group per time points. (* = p < 0.05).
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Cytokine profile detected in the lung tissue homogenates of DBA/2 mice infected separately with the three different M. tb strainsFigure 3
Cytokine profile detected in the lung tissue homogenates of DBA/2 mice infected separately with the three dif-
ferent M. tb strains. ELISA based cytokine assays were applied to determine the presence of cytokines. Supernatants were 
collected from lung homogenates of DBA/2 mice which were infected with ΔsigC mutant strain (), the complemented ΔsigC 
mutant () and the wild type strain, CDC1551 (). Each time point represents data from 5 mice and each was performed in 
triplicate. (* = p < 0.05; ** = p < 0.01).
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BMC Microbiology 2008, 8:151 http://www.biomedcentral.com/1471-2180/8/151decreased lung lesions and lower bacillary load (figure 1).
Such an observation was not detected with SCID mice
infected with the same mutant (data not shown). All three
groups had similar profiles of the three major cell types
identified (lymphocytes, monocytes/macrophages and
neutrophils), where neutrophils were the dominant cell
type in the BAL. The absence of a fully functional immune
system would render the SCID mice vulnerable to infec-
tion in general. Thus, it was not surprising to see a gradual
increase in CFU counts at day 1, 14, 21 and 28 post aero-
sol infection (figure 4A). At day 14, 21 and 28, a signifi-
cant drop of 1 log10 unit in CFU counts was observed
between the ΔsigC mutant infected mice and the
CDC1551 infected group (figure 4A). Mice infected with
the ΔsigC mutant survived 60 days longer than both the
CDC1551 and ΔsigC complemented mutant strain
infected mice (figure 4B). SCID mice infected with the
ΔsigC mutant strain produced detectable levels of several
cytokines one week after infection (figure 5). However,
the level of IL-1β gradually increased and became compa-
rable to the levels of the CDC1551 and the ΔsigC comple-
mented mutant groups by day 28. A similar trend was also
detected with TNF-α, IL-6 and IFN-γ, 21 days after infec-
tion. There were no differences in the levels of CCL-2 and
CCL-5 (data not shown) produced by the three groups of
mice. Like the DBA/2 mice (figure 3), the amount of IL-12
secreted by SCID mice was not different after infection
with the three M. tuberculosis strains.
Accelerated bacterial growth coincides with increased 
tissue damage in SCID mice
Lungs from the CDC1551 and the complemented mutant
groups developed severe tissue damage but the damage
was much milder for the ΔsigC mutant group. Lung sec-
tions analyzed from ΔsigC mutant infected mice had fewer
lesions 28 days (figure 6) post infection in contrast to
both the complemented mutant and CDC1551 infected
groups. Ziehl-Neelsen stainings confirmed the different
bacillary burden in the lungs of the three groups (figure
6). However at time of death (75–90 days post infection)
the lungs of the ΔsigC mutant group were as severe as both
the CDC1551 and complement control groups (data not
shown).
M. tuberculosis ΔsigC mutant displays a delayed growth 
in vivo (giv) phenotype in guinea pigs
M. tuberculosis infected guinea pigs produce well-formed
caseating granulomas in their lungs similar to humans,
while caseous necrosis is not routinely observed in mouse
lungs infected with M. tuberculosis [32]. To assess the role
of caseation necrosis in the survival of the M. tuberculosis
ΔsigC mutant, we studied its infection pattern following
aerosol inoculum in guinea pigs. Haematoxylin-eosin
(HE) staining confirmed that guinea pigs infected with the
ΔsigC mutant strain had fewer granulomas than the
CDC1551 wild type and ΔsigC complemented mutant
strains (figure 7A). Lung homogenates from guinea pigs
infected with either the CDC1551 wild type strain or the
ΔsigC complemented mutant strain showed the presence
of bacterial growth in the 7H10 agar plates, 4 and 8 weeks
post infection (figure 7B). However, the ΔsigC mutant
strain was undetectable (< 100 CFU) in guinea pigs at 4
weeks and reached detectable numbers of bacteria in their
lungs only at 8 weeks after infection. A similar observation
was seen in their spleens (data not shown). In addition,
while we were unable to keep M. tuberculosis ΔsigC mutant
infected guinea pigs for long-term survival studies, those
monitored to 8 weeks showed weight gain, good groom-
ing and did not appear ill compared with their counter-
parts infected with the wild type and complemented
mutant strains. These data show that the M. tuberculosis
ΔsigC mutant mounts a slower initial rate of growth and is
associated with fewer caseating lesions than in wild type.
Moreover, these observations suggest that compared to
mice, the M. tuberculosis ΔsigC mutant produces a more
delayed initial infection in guinea pigs. Based upon the
bacterial growth profiles defined in mice [16,17], this pat-
tern seen after ΔsigC mutant infection of guinea pigs is
most compatible with the defective growth in vivo (giv)
pattern.
Discussion
M. tuberculosis mutant strains which exhibit the imp phe-
notype and show milder lung pathology as well as pro-
longed host survival in comparison to the wild type strain
have been described [16,18-23]. In our current survival
study, gross pathology and histopathology revealed the
mild pathology with the ΔsigC mutant consistent with this
reduced pathology pattern. On the other hand, the lung
CFU counts of mice infected with the ΔsigC mutant strain,
while relatively high, began to lag three weeks post infec-
tion and remained between 1 to 1.5 log10 units lower than
the CDC1551 and ΔsigC complemented mutant strains.
In contrast to earlier studies of the ΔsigC mutant [20], the
lung CFU count showed relative containment compared
with the wild type; this occurrence could play a role in the
relative reductions in some of the inflammatory parame-
ters observed with the mutant. The major cell types infil-
trating the alveolar spaces of the CDC1551 and ΔsigC
complemented mutant strain infected mice were neu-
trophils, monocytes and lymphocytes. Interestingly, the
numbers of infiltrating neutrophils in the BAL of ΔsigC
mutant infected mice were at least 10-fold less than the
other two groups. Reduced levels of TNF-α, IL-1β, IL-6, IL-
12, IFN-γ, CCL-2 and CCL-5 were also detected in the lung
homogenates of ΔsigC mutant infected mice. However,
the lung is a separate compartment from the BAL and the
levels in one may not necessarily relate to the other.Page 7 of 14
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SCID mouse survival score and lung CFU countsFigure 4
SCID mouse survival score and lung CFU counts. The mean CFU counts were obtained from the lung homogenates of 
at least 5 mice per group and plated on 7H10 agar plates (A). SCID mice received ~100 CFU per mouse via the aerosol route 
and these mice were sacrificed for either CFU counts or immunological assays 1, 14, 21 and 28 after infection. Day one CFU 
counts were performed to confirm the dose of bacilli in each group. Statistically significant differences between mice infected 
with the ΔsigC mutant strain and the CDC1551 strain were seen at days 14, 21 and 28 (* = p < 0.05). (B) From the Kaplan-
Meier survival curve, the median survival for the ΔsigC mutant infected group is 86 days but 26 days for both the ΔsigC comple-
mented mutant and the wild type strain, CDC1551. This difference is significant with a log rank test p value of < 0.002.
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BMC Microbiology 2008, 8:151 http://www.biomedcentral.com/1471-2180/8/151These cytokines are commonly associated with the
inflammatory environment of M. tuberculosis infection
[3,4,7,9-12,33-37]. We did not examine the role of the
adaptive immune system in clearing M. tuberculosis infec-
tion. However, previous studies have placed a great
emphasis on the role of a T helper 1 (Th1) type response,
involving the engagement of CD4+ and CD8+ effector T
cells and the production of macrophage-activating
cytokines like IFN-γ, TNF-α and IL-12. Together with T
cells and NK cells, macrophages have been shown to
secrete TNF-α, IL-12 and IFN-γ during intracellular infec-
tions [38]. IFN-γ is an important mediator of macrophage
Cytokine profiles detected in the lung tissue homogenates of SCID mice infected separately with the three different M. tb strainsFigure 5
Cytokine profiles detected in the lung tissue homogenates of SCID mice infected separately with the three dif-
ferent M. tb strains. Supernatants were collected from lung homogenates of SCID mice which were infected with the ΔsigC 
mutant strain (), the ΔsigC complemented mutant () and the wild type strain, CDC1551 (). Mice were sacrificed at days 
1, 14, 21 and 28 after infection. Each time point represents data from 5 mice and each were performed in triplicate. (* = p < 
0.05; ** = p < 0.01; *** = p < 0.001).
 
0
500
1000
1500
2000
2500
1 14 21 28
Time (days)
pg
/m
l
0
500
1000
1500
2000
7 14 21 28
Time (days)
pg
/m
l
0
250
500
750
1000
1 14 21 28
Time (days)
pg
/m
l
0
100
200
300
400
500
1 14 21 28
Time (days)
pg
/m
l
0
100
200
300
1 14 21 28
Time (days)
pg
/m
l
** ** 
***
* 
*** 
0
100
200
300
1 14 21 28
Time (days)
pg
/m
l
TNF-D 
IL-1E 
IL-6 IL-12 
CCL-2/MCP-1 
IFN-J 
 'sigC U Complemented mutant  CDC1551 Page 9 of 14
(page number not for citation purposes)
BMC Microbiology 2008, 8:151 http://www.biomedcentral.com/1471-2180/8/151activation and regulation of this cytokine has been con-
sidered crucial in combating infection [8,11]. IL-12,
which induced IFN-γ production by lymphoid cells
[39,40], did not change significantly in this study. This
may be because we focused on the primary site of infec-
tion, i.e., the lung tissue homogenates, and not on lym-
phoid tissues. The lack of neutrophil infiltration and
reduced levels of pro-inflammatory cytokines like TNF-α,
IL-1β, IL-6 and IFN-γ in the lungs of ΔsigC mutant infected
mice may explain the milder disease in the DBA/2 and
SCID mice. However, in SCID mice a significant differ-
ence in cellular infiltration in the BAL was not observed.
Since neutrophils have been identified in tuberculous
lung granulomas in humans, guinea pigs and mice [41],
their role in granuloma formation has been suggested
[30,42,43]. Neutrophils have been shown to produce dif-
ferent chemokines which are crucial for bacterial clear-
ance [44,45]. Yet the levels of both CCL-2 and CCL-5 in
the lungs of ΔsigC mutant infected mice were marginal
and might not be involved in the recruitment of neu-
trophils in this study.
Both IL-1β and IL-6 are involved in the host immune
response to M. tuberculosis infection and are produced by
monocytes, macrophages, dendritic cells and neutrophils
[46]. IL-1β was detected in lung sections of tuberculosis
patients [47,48] and in the animal models [49,50]. This
cytokine has been postulated to play a role in restricting
the spread of the bacillary growth after M. tuberculosis
infection by forming granulomas [51,52]. Our data would
support this hypothesis because we saw severe granu-
loma-like lesions in the lungs of the CDC1551 and ΔsigC
complemented mutant groups but not among the ΔsigC
mutant infected mice where a lower concentration of IL-
1β was detected.
Guinea pigs form caseating granulomas in their lungs in
response to M. tuberculosis infection while infected mice
do not. In this study, ΔsigC mutant infected guinea pigs
had undetectable CFU counts 4 weeks after infection in
contrast to both the CDC1551 and the ΔsigC mutant com-
plemented infected groups. A recent study compared the
survival of identical pools of M. tuberculosis mutants in
both animal species after aerosol infection and found that
M. tuberculosis genes required for survival were cleared ear-
lier in guinea pigs than in mice [53]. Differences in host
response to the invading bacilli may be species specific
and the ΔsigC mutant strain can express a different pheno-
Lung sections from SCID mice 28 days post infectionFigur  6
Lung sections from SCID mice 28 days post infection. Lung sections were stained with haematoxylin and eosin (H&E) 
(a-c) (Magnification ×20). Ziehl-Neelsen staining detected for the presence of acid fast bacilli (AFB) in the lungs of the three 
groups of infected SCID mice (d-f) (Magnification ×1000).
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Guinea pig lungs and CFU countsFigure 7
Guinea pig lungs and CFU counts. Lung sections of guinea pigs, 8 weeks after aerosol exposure to ΔsigC mutant, the com-
plemented ΔsigC mutant and CDC 1551 were stained with haematoxylin and eosin (H&E) and analyzed under low power mag-
nification (A). (Magnification ×20). Guinea pig lung CFU counts 4 weeks and 8 weeks post aerosol infection (B). On day 0, each 
guinea pig received ~50 to 100 CFU but day 1 CFU counts were not performed. The mean CFU counts were obtained from 
lung homogenates of 3 guinea pigs per group and plated on 7H10 agar plates. (ND = not detected).
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BMC Microbiology 2008, 8:151 http://www.biomedcentral.com/1471-2180/8/151type in guinea pigs than in mice. Here we showed that the
ΔsigC mutant strain proliferated poorly with a growth in
vivo (giv) defect in guinea pigs. A similar finding was also
observed when guinea pigs and mice were infected with
the M. tuberculosis ΔdosR mutant strain [54]. Similar find-
ings have been recently reported in a study of several
sigma factor mutants evaluated in the guinea pig model
[55].
The major findings in this work are the low influx of neu-
trophils and reduced levels of known pro-inflammatory
cytokines which are associated with M. tuberculosis infec-
tion in the BAL of mice exposed to the ΔsigC mutant
strain. We selected the DBA/2 mouse strain for our study
because of it susceptibility to M. tuberculosis infection
hence fewer bacilli were required to induce the disease
[56]. These mice survived for more than one year after aer-
osol infection with the ΔsigC mutant strain and immuno-
logical analysis revealed that the attenuated mutant strain
was not as immunogenic as both the wild type and com-
plemented strain. Our data are similar to those in a recent
study looking at the immunological changes of suscepti-
ble mouse strains to M. tuberculosis (H37Rv) infection
[13]. In that study, elevated numbers of neutrophils in the
BAL correlated with higher susceptibility to succumbing
to M. tuberculosis infection. However, our study is the first
to show that neutrophil infiltration can be affected by an
attenuated M. tuberculosis mutant strain. Indeed, lipid het-
erogeneity, rather than genetic variations, is believed to be
the major cause of differences in pathogenicity between
strains [57,58]. Transcriptional profiling of the ΔsigC
mutant versus the wild type strain [20] revealed that genes
involved in biosynthesis of cofactors, cell wall compo-
nents, fatty lipids, energy metabolism, protein folding
and stabilization, and protein synthesis were downregu-
lated. Hence it will be of interest to investigate whether
such changes in the cell envelope may contribute to the
expression of the imp phenotype of the ΔsigC mutant
strain in mice.
Conclusion
We have found that the ΔsigC mutant with the imp pheno-
type is unable to trigger a strong early immune response.
This may occur due to a low influx of neutrophils and
reduced levels of pro-inflammatory cytokines. Our study
is the first to show that neutrophil infiltration can be
affected by an attenuated M. tuberculosis mutant strain.
Methods
Bacterial strains and culture conditions
The sigC mutant was constructed as described [20]. M.
tuberculosis CDC1551 wild type, ΔsigC deleted mutant and
the ΔsigC deleted complement mutant were cultured in
Middlebrook 7H9 (liquid medium containing 0.05%
TWEEN 80 and supplemented with OADC and 0.2% glyc-
erol) at 37°C and 0.5% CO2. At the appropriate times OD
readings at 600 nm were taken to determine bacterial den-
sity.
Mouse virulence assays
Female DBA/2 and CB17-SCID mice were infected by the
aerosol route by placing liquid inoculum into the neb-
ulizer of a Glass-Col aerosol machine and running the
standard program. Their lungs were implanted with ~100
bacteria per lung at day 0 of the experiment. At day 1,
lungs were collected separately and homogenized and
dilutions plated onto 7H10 agar plates to confirm that
comparable numbers of bacteria were implanted per
mouse lung. The bacteria were incubated at 37°C and the
colony forming units (CFU) determined.
Guinea pig infection
Female outbred Hartley guinea pigs (~500 g) were
infected using a Madison aerosol generation chamber cal-
ibrated to deliver approximately 50 to 100 bacteria per
lung at day 0. Three to five animals were sacrificed 4 and
8 weeks post infection and their entire lungs homoge-
nized for CFU counts.
Cytokine Assay
Supernatants from homogenized lungs were collected and
passed through a 0.22 μM Millipore filter. Using the Duo-
Set ELISA kits from R&D Systems, (Minneapolis, MN)
supernatants were tested for the presence of CCL-2, CCL-
5, TNF-α, IL-6, IL-1β, IL-4, IL-12p70 and TGF-β1. IL-10
and IFN-γ sandwich ELISAs were performed using rea-
gents from MabTech (Cincinatti, OH). Cytokine assays
were conducted according to the instructions provided by
the manufacturers.
BAL and Cytosmear
Bronchoalveolar lavage cells (BAL) were harvested by
exposing the trachea and excising a small incision using a
scissor. A blunt needle connected to a 1 ml syringe is
inserted into the cut and ice cold PBS is gently flushed into
the trachea and lungs. BAL cells were washed twice at
1200 RPM for 7 min at 4°C and resuspended in PBS with
1% FCS. 100 μl of BAL cells was mounted on a glass slide
with cytospin centrifugation (StatSpin Cytofuge 2) and
sealed. Slides were air dried overnight and stained with
Protocol HEMA 3 stain set and differential cell counts per-
formed.
Histopathology
Lungs were excised from all animals and stored in 10%
formalin, embedded and stained with haematoxylin and
eosin (H&E) for pathological analysis or with Ziehl-
Nielsen stain to evaluate the presence of acid fast bacilli in
these organs.Page 12 of 14
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BMC Microbiology 2008, 8:151 http://www.biomedcentral.com/1471-2180/8/151Statistical analysis
The GraphPad Prism 4 software program was used to per-
form all statistical analysis (GraphPad Software Inc., San
Diego, CA). Kaplan-Meier analysis was used to determine
statistical significance of the differences in survival of
mice. The statistical significance of three-way compari-
sons was tested by two-way analysis of variance (ANOVA)
with Bonferroni post-tests.
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